CirCode Biomed Announces FDA Clearance for IND Application of HM2002, the world's first circular RNA drug being administrated in patients ...Middle East

SHANGHAI, May 30, 2025 /PRNewswire/ -- Shanghai CirCode Biomed Co. Ltd. (CirCode), an innovative biotech company pioneering circular RNA therapies, recently announced that its leading pipeline HM2002 received Investigational New Drug (IND) clearance from the US Food and Drug...

Read More Details
Finally We wish PressBee provided you with enough information of ( CirCode Biomed Announces FDA Clearance for IND Application of HM2002, the world's first circular RNA drug being administrated in patients )

Also on site :

• Beloved 'Doctor Who' Star, 42, Returns to the Series in Surprise Twist
• South Korea’s snap presidential election 2025: All you need to know
• Man in custody after three police officers seriously injured during arrest